Halichondrin B
Halichondrin B is a complex polyether macrolide originally isolated from the marine sponge Halichondria okadai. It is notable for its potent antimitotic activity, which has made it a subject of interest in the development of anticancer therapies.
Structure and Properties[edit | edit source]
Halichondrin B is characterized by its large and intricate molecular structure, which includes multiple ether rings and a long carbon chain. The molecule's complexity has posed significant challenges for chemical synthesis, but it has also provided a rich area of study for organic chemistry.
Biological Activity[edit | edit source]
Halichondrin B exerts its biological effects by binding to tubulin, a protein that is essential for microtubule formation. By inhibiting tubulin polymerization, Halichondrin B disrupts the mitotic spindle, leading to cell cycle arrest and apoptosis in rapidly dividing cells. This mechanism of action is similar to that of other microtubule-targeting agents like taxanes and vinca alkaloids.
Clinical Development[edit | edit source]
Due to its potent antimitotic activity, Halichondrin B has been investigated as a potential anticancer agent. A synthetic analog of Halichondrin B, known as eribulin, has been developed and approved for the treatment of certain types of breast cancer and liposarcoma. Eribulin retains the core structure of Halichondrin B but is more amenable to large-scale synthesis and clinical use.
Synthesis[edit | edit source]
The total synthesis of Halichondrin B has been a significant achievement in the field of organic chemistry. The first successful synthesis was reported by the research group of Yoshito Kishi in 1992. This synthesis required over 100 steps and showcased the advanced techniques and strategies used in modern synthetic chemistry.
Related Compounds[edit | edit source]
Halichondrin B is part of a larger family of related compounds known as halichondrins, which share similar structural features and biological activities. Other members of this family include Halichondrin A and Halichondrin C, although Halichondrin B is the most extensively studied.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
